☆ 4.2 Article

COVID-19 Pneumonia in Vaccinated Population: A Six Clinical and Radiological Case Series

MEDICINA-LITHUANIA (2021)

Related references

Note: Only part of the references are listed.

Article Radiology, Nuclear Medicine & Medical Imaging

Use of Chest Imaging in the Diagnosis and Management of COVID-19: A WHO Rapid Advice Guide

Elie A. Akl et al.

Summary: The World Health Organization developed a rapid guide on the use of chest imaging in the diagnosis and management of COVID-19, including recommendations for patients with varying disease severity levels, from outpatient or hospital care to home discharge. The recommendations are conditional and based on low certainty evidence, expert opinion, aiming to provide guidance on choosing the appropriate imaging modality and implementation considerations.

RADIOLOGY (2021)

Add to Collection

Review Biochemical Research Methods

Coronavirus Disease 2019-Related Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis

Ji-Gan Wang et al.

Summary: Several studies have shown that multisystem inflammatory syndrome in children associated with COVID-19 presents with a variety of clinical manifestations involving multiple organ systems, and timely treatment can lead to a lower mortality rate.

BIOCHEMISTRY RESEARCH INTERNATIONAL (2021)

Add to Collection

Letter Emergency Medicine

Cardiac arrest secondary to Covid19 pneumonia post full vaccination

Eslam Mohamed et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Editorial Material Otorhinolaryngology

COVID-19 Vaccines May Not Prevent Nasal SARS-CoV-2 Infection and Asymptomatic Transmission

Benjamin S. Bleier et al.

Summary: Current COVID-19 vaccine candidates, administered by injection to produce an IgG response, may not fully prevent viral shedding in the nasal cavity, potentially allowing transmission. Otolaryngology providers should continue taking precautions to protect vulnerable patients until further knowledge on mucosal immunity post-systemic vaccination is acquired.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2021)

Add to Collection

Review Cell Biology

COVID-19: Characteristics and Therapeutics

Rameswari Chilamakuri et al.

Summary: The novel coronavirus (COVID-19) has significantly impacted the world since its emergence at the end of 2019, but there have been major advancements in our understanding of the virus and development of treatment options and vaccines to control the pandemic.

CELLS (2021)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

Michael A. Johansson et al.

Summary: The study suggests that more than half of COVID-19 transmission may come from asymptomatic individuals, highlighting the importance of measures beyond identifying and isolating symptomatic cases in controlling the spread of the virus.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Medicine, General & Internal

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey et al.

Summary: The AZD1222 vaccine has been approved for emergency use in the UK with an interval of 4-12 weeks between doses. Analysis shows that the vaccine is efficacious with two doses and provides immunoprotection after the first dose before the second dose is administered.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

Florian Krammer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Rheumatology

SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response

Michael Markus Bonelli et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

News Item Multidisciplinary Sciences

Five reasons why COVID herd immunity is probably impossible

Christie Aschwanden

Summary: Despite vaccination efforts in full force, the theoretical threshold for conquering COVID-19 appears to be unattainable.

NATURE (2021)

Add to Collection

Review Microbiology

SARS-CoV-2 Antiviral Therapy

Kaiming Tao et al.

Summary: This review summarizes a year of progress in developing antiviral therapies for COVID-19, covering efforts in preclinical and clinical drug development, with a focus on compounds inhibiting SARS-CoV-2 enzymes, virus entry, interferons, and repurposed drugs inhibiting host processes for viral replication. Additionally, it concludes with insights on lessons learned and challenges ahead in SARS-CoV-2 drug development.

CLINICAL MICROBIOLOGY REVIEWS (2021)

Add to Collection

Article Infectious Diseases

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel

Yaniv Lustig et al.

Summary: The study found that healthcare workers vaccinated with Comirnaty showed reduced neutralising titres against the Gamma, Beta, and Delta variants, but the remaining neutralisation capacity may still be protective.

EUROSURVEILLANCE (2021)

Add to Collection

Article Infectious Diseases

An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021

Sarah V. Williams et al.

Summary: An outbreak of the SARS-CoV-2 Delta variant occurred in a London care home, where most infected individuals had received a single dose of the Vaxzevria vaccine. Despite the high vaccination rate, the attack rate was still significant, though there were no fatalities.

EUROSURVEILLANCE (2021)

Add to Collection

Article Infectious Diseases

Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples

Pedro Brotons et al.

Summary: The study validated and implemented a simple, rapid, and accurate method for direct RT-qPCR testing of self-collected raw saliva. Results showed high detection efficiency and potential applications in asymptomatic health workers and teenagers.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Infectious Diseases

Re-infection with a different SARS-CoV-2 clade and prolonged viral shedding in a hematopoietic stem cell transplantation patient

Abeer N. Alshukairi et al.

Summary: This case report discusses the challenges faced in clinical and public health management of immunocompromised patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The patient, a hematopoietic stem cell transplantation patient with lymphoma, required three consecutive hospital admissions and had confirmed infection with two different SARS-CoV-2 clades. Clinical management issues and unanswered questions arising from this case are highlighted.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Letter Infectious Diseases

Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?

Nouara Yahi et al.

JOURNAL OF INFECTION (2021)

Add to Collection

Article Oncology

Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab

Gianpaolo Marcacci et al.

Summary: Patients with non-hodgkin lymphomas may exhibit unique dynamics in COVID-19 due to their disease-related immunodeficiencies, requiring regular molecular and antibody testing, as well as personalized treatment strategies.

INFECTIOUS AGENTS AND CANCER (2021)

Add to Collection

News Item Critical Care Medicine

Lifting of COVID-19 restrictions in the UK and the Delta variant

Talha Khan Burki

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Clinical Neurology

Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis

Gauruv Bose et al.

Summary: A 32-year-old woman with highly active MS was infected with SARS-CoV-2 while on treatment with rituximab. She recovered and was symptom-free for 21 days before receiving rituximab and IVIg for comorbid hypogammaglobulinemia, but redeveloped respiratory symptoms three days after the infusion.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021

Catherine M. Brown et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Review Immunology

Factors Affecting the Antibody Immunogenicity of Vaccines against SARS-CoV-2: A Focused Review

Zhangkai Jason Cheng et al.

Summary: Research on the immunogenicity of COVID-19 vaccines, as well as influencing factors such as age, infection history, and virus variants, can help us better understand the vaccines' effects and recommend vaccination programs. Suggestions are made to address concerns raised by the shortened development cycle of vaccines and the immunity escape phenomenon of virus variants. Future prospects for vaccines are outlined based on the principle of ADE and experience with similar viruses.

VACCINES (2021)

Add to Collection

Article Medicine, General & Internal

Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization

Gabriel Chodick et al.

Summary: The short-term effectiveness of the first dose of the BNT162b2 vaccine against SARS-CoV-2 infection 13 to 24 days after immunization in a real-world setting was assessed, showing comparable results to the phase III randomized clinical trial.

JAMA NETWORK OPEN (2021)

Add to Collection

Letter Rheumatology

COVID-19 vaccine failure in a patient on rituximab therapy

Sridhar Chilimuri et al.

RHEUMATOLOGY ADVANCES IN PRACTICE (2021)

Add to Collection

Article Immunology

Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021

Nicolas Vignier et al.

Summary: An outbreak of severe acute respiratory syndrome coronavirus 2 caused by the Gamma variant infected 55% of employees at a gold mine in French Guiana, with 87% showing symptoms but no severe cases. Among fully vaccinated miners, the attack rate was 60%, while it was 75% among unvaccinated miners without a history of infection.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, Research & Experimental

One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19

Riccardo Levi et al.

Summary: A study showed that individuals with prior exposure to SARS-CoV-2 had a significant increase in antibody response within 5 to 18 days after receiving the Pfizer/BioNTech vaccine. Symptomatic individuals reached a high titer of antibodies with just one dose, suggesting that a second dose may not be necessary.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 Detection in Fecal Sample from a Patient with Typical Findings of COVID-19 Pneumonia on CT but Negative to Multiple SARS-CoV-2 RT-PCR Tests on Oropharyngeal and Nasopharyngeal Swab Samples

Barbara Brogna et al.

Summary: Despite negative results in upper respiratory tract RT-PCR tests, detection of SARS-CoV-2 in stool samples can be a rapid and useful approach to confirm COVID-19 diagnosis in cases with discrepancies between clinical symptoms, chest CT findings, and upper respiratory tract RT-PCR test results.

MEDICINA-LITHUANIA (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Michael Chung et al.

RADIOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic

Aishwarya Gulati et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2020)

Add to Collection

Article Critical Care Medicine

The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic A Multinational Consensus Statement From the Fleischner Society

Geoffrey D. Rubin et al.

CHEST (2020)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

COVID-19 patients and the radiology department - advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI)

Marie-Pierre Revel et al.

EUROPEAN RADIOLOGY (2020)

Add to Collection

Review Medicine, Research & Experimental

Monoclonal antibody as a potential anti-COVID-19

Leila Jahanshahlu et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Add to Collection

Article Medicine, General & Internal

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Maheshi N. Ramasamy et al.

LANCET (2020)

Add to Collection

Review Biochemistry & Molecular Biology

A systematic review on recent trends in transmission, diagnosis, prevention and imaging features of COVID-19

S. Manigandan et al.

PROCESS BIOCHEMISTRY (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

The effect of aging of the immune system on vaccination responses

Janet M. Lord

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)

Add to Collection

Article Hematology

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment

Olav Erich Yri et al.

BLOOD (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.